• INVESTOR RELATIONS
    Corporate Governance
    Operating income
    Operation revenue
    25.435 Billion
    Year-on-year increase
    3.71 %
    Net profit margin
    1.33 Billion
    R&D investment
    Research and development expenditure
    1.47 Billion
    Year-on-year increase
    0.59 %
    2023 Research and development expenditure
    1.462 Billion
    2022 Research and development expenditure
    0.967 Billion
    2021 Research and development expenditure
    0.81 Billion
    2020 Research and development expenditure
    0.591 Billion
    *Unit: CNY Billion
    Periodic Temporary
    Investor Interaction

    If you would like to know about investor relations, please contact us:

    ADD: No.666 Gaoxin Road, East Lake High-tech Development Zone, Wuhan, Hubei, China
    Email: renfu.pr@renfu.com.cn